Revance Therapeutics Inc (NASDAQ:RVNC)

During the Trading Day
23.30 +0.97 / +4.34%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
23.30 0.00 / 0.00%
 
Volume: 11.2K
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close22.33
Today’s open22.60
Day’s range22.15 - 23.37
Volume136,760
Average volume (3 months)132,847
Market cap$534.5M
Dividend yield--
Data as of 3:59pm ET, 04/20/2015

Growth & Valuation

Earnings growth (last year)-408.57%
Earnings growth (this year)-2.06%
Earnings growth (next 5 years)--
Revenue growth (last year)-37.93%
P/E ratioNM
Price/Sales857.68
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
LBIOLion Biotechnologies...-0.17-1.40%
ADXSAdvaxis Inc+0.53+2.72%
IMDZImmune Design Corp-0.09-0.34%
SRPTSarepta Therapeutics...+0.30+2.27%
Data as of 4:00pm ET, 04/20/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$383.0K
Annual profit (last year)-$62.9M
Net profit margin-16,427.42%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
CFO &
Executive VP-Corporate Development
Lauren P. Silvernail
Corporate headquarters
Newark, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers